Related Experiment Video
Updated: Sep 25, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management
Mark H Rosenberg1, Laurie J Deerfield, Edward M Baruch
1Department of Psychiatry, School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey, Cherry Hill, New Jersey 08002-2000, USA. markrosenberg@bigfoot.com
Abstract:
Many psychiatric professionals are unfamiliar with gamma-hydroxybutyrate (GHB), an increasingly popular drug of abuse. GHB withdrawal can lead to psychosis and agitation, and patients may present to psychiatric facilities for treatment. Withdrawal may progress to delirium, with the potential for severe or even fatal medical complications. Therefore, it is imperative for psychiatric professionals to understand how to treat these patients. In this article, we describe two cases of severe GHB withdrawal syndrome that were treated in our inpatient psychiatric unit. These are among the most severe cases reported. Pertinent literature is reviewed and suggestions for treatment are discussed.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
CNS Depressants: Barbiturates and Benzodiazepines
Pharmaceutical Poisoning: Treatment Strategies
CNS Depressants: Alcohol and Nicotine
Prevention of Further Absorption of Poison
Hypoglycemia and Glucagon
